We don’t expect the COVID-19 vaccine sales to affect our fair value estimate.
We maintain our valuations and wide moat and negative trend ratings for the cigarette makers as reports have surfaced that the Biden administration is considering lowering the nicotine and menthol levels in cigarettes.
Market volatility and security concerns increased mainframe capacity needs, leading to nearly 50% year-over-year growth in the seventh quarter since the z15 model’s launch.
The strategic framework is intact following IPO plans at Coca-Cola Beverages Africa.
We are raising our fair value estimates for Carnival and Royal Caribbean.
We don’t anticipate a material change to our $70 fair value estimate.
We are maintaining our fair value estimate, but we have raised our expectations for operations.
We're increasing our fair value estimate to $76 per share from $74.
We think shares are overvalued but would be buyers on a pullback.
We don't plan on making a change to the wide-moat company's fair value estimate.
Annualized organic AUM growth of 6.8% was well above our long-term target of 3%-5% annually for the wide-moat company.
With roughly flat net interest income compared with last quarter and higher fee income, revenue is generally holding up.
We're maintaining our fair value estimates for both firms.
We're maintaining our fair value estimate of $52 per share.
We are increasing our fair value estimate for the wide-moat bank after an excellent first quarter.
We expect the pause to be temporary because of the rarity of the adverse events—six cases among the more than 6.8 million doses administered in the U.S.
We are maintaining our fair value estimate after Microsoft announced the acquisition of Nuance Communications, a leader in conversational artificial intelligence.
We continue to view American Electric Power as an attractive long-term holding.
The Biden administration released the initial details of its infrastructure plan, proposing $2 trillion in spending over eight years, including $621 billion for transportation infrastructure.
We intend to modestly raise our fair value estimate based on this near-term strength as its COVID-19 vaccine was the highlight of the quarter.
This latest mis-step reinforces our view that Credit Suisse's problems are not only legacy issues but that there is a deeper institutional problem that needs to be addressed.
We are maintaining our moat rating and fair value estimate for the media company after a tumultuous week.
The overall strong innovation seen with the vaccine and pipeline reinforces our conviction in the firm’s wide moat.
We see strength on all fronts of quarterly performance. New customer engagement levels remained strong and activity on adobe.com remains elevated as a result of the extended remote work environment. As software has lagged early in 2021, we see shares as increasingly attractive.
The wide-moat firm's vaccine showed a solid 79% efficacy level in preventing symptomatic COVID-19, which was better than we had expected.
Although inventory shortages impacted sales, we see them as temporary and not reflective of high underlying demand. This stance is reflected in Nike’s guidance of 75% sales growth (against an easy comparison due to the outbreak last year) for the fourth quarter versus our prior 66% estimate.
Here is where our valuations stand with Berkshire's various segments.
We are maintaining our fair value estimate as the split bears no bearing on the intrinsic value.
We expect Slack shares to move toward our fair value estimate as the closing date approaches.
We suggest investors await a greater margin of safety, as Costco faces an uncertain normalization of spending habits once the pandemic ebbs.
We think much of Cash App’s recent success has come from Square’s efforts to build out ancillary services on the platform, and this could provide another tie-in.
While this may lower the effectiveness of ads, it will address some data privacy concerns.
The company is not planning on pivoting from its core oil and gas business.
We are raising our fair value estimate for the narrow-moat company.
Our fair value estimate will increase, leaving shares overvalued.
We plan to increase our fair value estimate for the no-moat company.
We see a long runway for growth as the company gains traction with Zoom Phone and evolves its main application to a communication platform, and we are impressed by management’s ability to overdeliver in terms of both growth and margins. Given exceptional results, strong guidance, and our annual model roll, we are once again raising our estimates, which drives our fair value estimate to $223 per share from $176.
This adds support for U.S. herd immunity by summer.
We expect to raise our fair value estimate following a stronger conclusion to the company's fiscal year than we had been projecting.
We raised our fair value estimate to $52, but shares are still overvalued.
We are lowering our fair value estimate of AB InBev to $90 per ADR from $96 to account for the likelihood of extended margin pressure in 2021.
Wide-moat Salesforce reported solid fiscal fourth-quarter results, including upside to both revenue and non-GAAP EPS expectations. We are raising our fair value estimate to $265 per share, from $253, based on rolling our forecast and the solid near-term results and guidance.
As vaccines continue to be distributed, we expect travel demand to rebound strongly in the second half of 2021, with Airbnb’s full-year 2021 revPAR returning close to 2019 levels.
Nvidia reported impressive fourth-quarter results with revenue ahead of management’s guidance.
We believe the stock trades on the option value of what it may look like years from now rather than on fundamentals and free cash flow generation.
We plan to modestly increase our fair value estimate.
We plan to increase our $210 fair value estimate but still see shares as rich.
We suggest investors await a more attractive entry point.
While the company raised an estimated $10.6 billion during the period by selling positions in 11 different stocks, the trimming of stakes in Apple (57.2 million shares for an estimated $7.1 billion) and Wells Fargo (75.0 million shares for $2.0 billion) accounted for most of the capital raised.
We are raising our fair value estimate for the narrow-moat firm.